Determination of the optimal immunizing dose of heterologous goat pox virus vaccine (Poxviridae: Chordopoxvirinae: Capripoxvirus) against lumpy skin disease

Cover Image

Cite item

Full Text

Abstract

Introduction. Lumpy skin disease (LSD), sheep pox and goat pox are dangerous diseases of domestic ruminants. Representatives of the genus of capripoxviruses are antigenically similar and can be used as a vaccine for three infections, as in the case of representatives of the genus of orthopoxviruses, which includes viruses of smallpox, monkeypox, and cowpox, that all belong to a single family Poxviridae.

Materials and methods. In this study, the vaccine strain G20-LKV of the goat pox virus and the virulent strain RIBSP-2019/K of the LSD virus were used. The experiments were carried out on clinically healthy cattle of the Kazakh White-headed breed, aged six to eight months. Virological and serological research methods were used in the work.

Results. All immunized animals that received different doses of the vaccine showed resistance to the infection challenge, without showing any clinical signs of the disease. In animals that received the lowest doses of the vaccine 15,000, 30,000 and 40,000 TCID50, no adverse events, skin and temperature reactions were observed at the injection site. Those vaccinated with high doses of the vaccine had a local reaction in the form of swelling at the site of vaccine administration. Control animals infected with a virulent virus showed clinical signs of the cattle lumpy skin disease .

Conclusion. The vaccine, prepared based on the “G20-LKV” strain of the goat virus, is protective for cattle against infection with a virulent LSD virus at immunizing doses from 15,000 to 80,000 TCID50, which are dependent on the LSD epizootic situation in particular region.

About the authors

Ruslan T. Abitaev

RSE “Research Institute for Biological Safety Problems” of Ministry of Health of the Republic of Kazakhstan

Email: erbol_km@mail.ru
ORCID iD: 0000-0001-5609-2491
Kazakhstan, 080409, Gvardeyskiy vill., Zhambyl region, Korday district

Zhanat B. Kondibaeva

RSE “Research Institute for Biological Safety Problems” of Ministry of Health of the Republic of Kazakhstan

Email: erbol_km@mail.ru
ORCID iD: 0000-0002-8224-8047
Kazakhstan, 080409, Gvardeyskiy vill., Zhambyl region, Korday district

Zhanat T. Amanova

RSE “Research Institute for Biological Safety Problems” of Ministry of Health of the Republic of Kazakhstan

Email: erbol_km@mail.ru
ORCID iD: 0000-0002-3987-6814
Kazakhstan, 080409, Gvardeyskiy vill., Zhambyl region, Korday district

Zhanna Z. Sametova

RSE “Research Institute for Biological Safety Problems” of Ministry of Health of the Republic of Kazakhstan

Email: erbol_km@mail.ru
ORCID iD: 0000-0002-2332-2841
Kazakhstan, 080409, Gvardeyskiy vill., Zhambyl region, Korday district

Abdurahman K. Ussembay

RSE “Research Institute for Biological Safety Problems” of Ministry of Health of the Republic of Kazakhstan

Email: erbol_km@mail.ru
ORCID iD: 0000-0003-3639-3793
Kazakhstan, 080409, Gvardeyskiy vill., Zhambyl region, Korday district

Yerbol A. Bulatov

RSE “Research Institute for Biological Safety Problems” of Ministry of Health of the Republic of Kazakhstan

Author for correspondence.
Email: erbol_km@mail.ru
ORCID iD: 0000-0001-8543-4219

PhD (Biol.), Head of the Laboratory of Technology of cultivation of Microorganisms, RSE “Research Institute for Biological Safety Problems” of Ministry of Health of the Republic of Kazakhstan

Kazakhstan, 080409, Gvardeyskiy vill., Zhambyl region, Korday district

References

  1. Tuppurainen E.S.M., Venter E.H., Shisler J.L., Gari G., Mekonnen G.A., Juleff N., et al. Capripoxvirus diseases: current status and opportunities for control. Transbound. Emerg. Dis. 2017; 64(3): 729–45. https://doi.org/10.1111/tbed.12444.
  2. Babiuk S. Vaccines against lumpy skin disease virus and vaccination strategies. In: Tuppurainen E., Babiuk S., Klement E., eds. Lumpy Skin Disease. Berlin: Springer; 2018.
  3. Barnard B.J., Munz E., Dumbell K., Prozesky L. Lumpy skin disease. In: Coetzer J.A.W., Thomson G.R., Tustin R.C., eds. Infectious Diseases of Livestock. Cape Town, South Africa: Oxford University Press; 1994: 604–12.
  4. Babiuk S., Bowden T.R., Boyle D.B., Wallace D.B., Kitching R.P. Capripoxviruses: An emerging worldwide threat to sheep, goats and cattle. Transbound. Emerg. Dis. 2008; 55(7): 263–72. https://doi.org/10.1111/j.1865-1682.2008.01043.x
  5. Carn V.M., Kitching R.P. The clinical response of cattle experimentally infected with lumpy skin disease (Neethling) virus. Arch. Virol. 1995; 140(3): 503–13. https://doi.org/10.1007/BF01718427
  6. Abutarbush S.M., Tuppurainen E.S.M. Serological and clinical evaluation of the Yugoslavian RM65 sheep pox strain vaccine use in cattle against lumpy skin disease. Transbound. Emerg. Dis. 2018; 65(6): 1657–63. https://doi.org/10.1111/tbed.12923
  7. WHO. Fact sheet. Monkeypox. Available at: https://www.who.int/news-room/fact-sheets/detail/monkeypox
  8. Ben-Gera J., Klement E., Khinich E., Stram Y., Shpigel N.Y. Comparison of the effcacy of Neethling lumpy skin disease virus and х10 RM65 sheep-pox live attenuated vaccines for the prevention of lumpy skin disease – the results of a randomized controlled field study. Vaccine. 2015; 33(38): 4837–42. https://doi.org/10.1016/j.vaccine.2015.07.071
  9. Bhanuprakash V., Indrani B.K., Hegde R., Kumar M.M., Moorthy A.R.S. A classical live attenuated vaccine for sheep pox. Trop. Anim. Health Prod. 2004; 36(4): 307–20. https://doi.org/10.1023/B:TROP.0000026661.88631.50.
  10. Tuppurainen E.S.M., Antoniou S.E., Tsiamadis E., Topkaridou M., Labus T., Debeljak Z., et al. Field observations and experiences gained from the implementation of control measures against lumpy skin disease in South-East Europe between 2015 and 2017. Prev. Vet. Med. 2020; 181: 104600. https://doi.org/10.1016/j.prevetmed.2018.12.006
  11. Kitching R.P., Bhat P.P., Black D.N. The characterization of African strains of capripoxvirus. Epidemiol. Infect. 1989; 102(2): 335–43. https://doi.org/10.1017/s0950268800030016
  12. Tulman E., Alfonso C., Lu Z., Zsak L., Sur J.H., Sandybaev N., et al. The genomes of sheep pox and goat pox viruses. J. Virol. 2002; 76(12): 6054–61. https://doi.org/10.1128%2FJVI.76.12.6054-6061.2002
  13. Kitamura T., Kitamura Y., Tagaya I. Immunogenicity of an attenuated strain of vaccinia virus on rabbits and monkeys. Nature. 1967; 215(5106): 1187–8. https://doi.org/10.1038/2151187a0
  14. Zhugunissov K., Bulatov Ye., Orynbayev M., Kutumbetov L., Abduraimov Ye., Shayakhmetov Ye., et al. Goatpox virus (G20-LKV) vaccine strain elicits a protective response in cattle against lumpy skin disease at challenge with lumpy skin disease virulent field strain in a comparative study. Vet. Microbiol. 2020; 245: 108695. https://doi.org/10.1016/j.vetmic.2020.108695.
  15. Brenner J., Haimovitz M., Oron E., Stram Y., Fridgut O., Bumbarov V., et al. Lumpy skin disease (LSD) in a large dairy herd in Israel, June 2006. Isr. J. Vet. Med. 2006; 61(3/4): 73–7.
  16. Coakley W., Capstick P.B. Protection of cattle against lumpy skin disease. Factors affecting small scale production of tissue culture propagated virus vaccine. Res. Vet. Sci. 1961; 2(4): 369–71. https://doi.org/10.1016/S0034-5288(18)34941-5
  17. Capstick P.B. Vaccines for lumpy skin disease, sheep pox and goat pox. Dev Biol (Basel) 2003;114:161-7.
  18. Capstick P.B. Veterinary Department Annual Report. Kenya; 1961: 45–47.
  19. Kitching R.P., Hammond J.M., Taylor W.P. A single vaccine for the control of capripox infection in sheep and goats. Res. Vet. Sci. 1986; 42(1): 53–60.
  20. Kitching R.P., Taylor W.P. Clinical and antigenic relationship between isolates of sheep and goat pox viruses. Trop. Anim. Health Prod. 1985; 17(2): 64–74. https://doi.org/10.1007/bf02360774
  21. Davies F.G., Krauss H., Lund L.J., Taylor M. The laboratory diagnosis of lumpy skin disease. Res. Vet. Sci. 1971; 12(2): 123–7.
  22. Gari G., Abie G., Gizaw D., Wubete A., Kidane M., Asgedom H., et al. Evaluation of the safety, immunogenicity and efficacy of three capripoxvirus vaccine strains against lumpy skin disease virus. Vaccine. 2015; 33(28): 3256–61. https://doi.org/10.1016/j.vaccine.2015.01.035
  23. Abduraimov E.O. Development of Manufacturing Technology for Goatpox Virus Vaccine. Dissertation for the Degree of Candidate of Veterinary Science [Razrabotka tekhnologii izgotovleniya virusvaktsiny protiv ospy koz. Dissertatsiya na soiskaniya kandidata veterinarnykh nauk]. Almaty; 2001. (in Russian)

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig. Skin reaction of vaccinated and control animals: a – the place of administration of the virulent virus to vaccinated animal (day 1); b – the vaccinated animal after the infection challenge (day 8); c – the place of administration of the virulent virus to control animal (day 1); d – necrotic nodules on the skin of the control animal (day 12); e – subcutaneous changes during autopsy of the control animal.

Download (320KB)
Indexing metadata

Copyright (c) 2022 Abitaev R.T., Kondibaeva Z.B., Amanova Z.T., Sametova Z.Z., Ussembay A.K., Bulatov Y.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies